macrophages. These macrophage also releases adipokines in state of obesity. These adipokines are proinflammatory cytokines which in excess leads to systemic chronic low grade inflammatory state. 4 The C-reactive protein (CRP) is the first cytokine to be elevated in inflammatory conditions such as obesity. A strong relationship between obesity and CRP has been observed in all populations. Many studies have shown a link between obesity and derangements in iron parameters. Increased body adipose tissue, particularly visceral deposits, is associated with increased risk of iron deficiency which may be masked by high serum ferritin levels, presumably because the increase cytokines result in increased acute phase reactant synthesis resulting in increased macrophage sequestration and/or decreased intestinal absorption. 6 Increased proinflammatory cytokines result in increased hepcidin synthesis and secretion. Hepcidin due to its negative control over Ferroportin, the primary iron exporter from the gut to plasma transferrin, results in decreased iron absorption. Hepcidin also causes sequestration of iron in macrophages and decreased availability of iron for Hemoglobin synthesis. 5 Increased acute phase reactant synthesis seen in inflammatory states has been evolved to primarily deprive microbes of iron in the body. Generally premenopausal women are at higher risk for iron deficiency anemia. Regular menstrual loss, low iron intake and restrictive diets for losing weight increases the risk of iron deficiency among this group. Maternal iron deficiency has adverse effects on birth consequences, neonatal cognitive development and increased risk of postpartum depression. Therefore, insufficient iron level is an important issue which necessitates further studies of iron status among this population. In this study, we aimed to evaluate iron status and its association with obesity by studying iron biomarkers in a group of premenopausal obese women.
METHODS
The aims and objectives of this study to identify Obese women using Body Mass Index.(japi2009 Indian criteria).
• To evaluate S.iron, TIBC and S.ferritin values in both obese women and normal BMI women. • To compare S.iron, TIBC and S.ferritin values in obese women and normal BMI women. • Association of S.iron, TIBC and S.ferritin with BMI.
The study was done on 100 patients which were divided into two groups. Group A included 50 obese women (BMI>25kg/m2) in age group of 16-45 years. Group B consisted of 50 control women in age group of 16-45 with normal range BMI. Serum iron levels, Total Iron binding capacity and Serum Ferritin levels were measured in all patients included in the study. These cases were compared with controls. This was a case-control study conducted at OPD/IPD/EMERGENCY of SGRD Hospital, Vallah, Sri Amritsar over a period of 1.8 years from Jan 2018 to Aug 2019. Written consent for the trial was obtained from all patients for participating in the study.
Inclusion criteria (Group A)
This study population will include 50 obese premenopausal women aged between 16 to 45 with a measured body mass index (BMI) ≥ 25 Kg/m² (japi2009 Indian criteria).
Exclusion criteria
Diabetes, Hypothyroidism and Cushing disease, Hepatic disease including hemochromatosis, Renal disorder, Malignancy, Pregnancy or breast feeding, Infectious diseases, Bleeding disorders, Gastrointestinal bleed, Menorrhagia.
Hormonal contraceptive methods, or intake of specific drugs or substances(ACE Inhibitors, Levothyroxine, quinolones, carbidopa decreases iron absorption) which influence iron profile, body weight and inflammatory conditions such as zinc supplements and bariatric surgery.
Those who report iron supplementation, blood transfusion or donation will be recruited in the study after a washout period of 3 months. Subjects that received vitamin supplements, fish oil and minerals will be included in the study after a washout period of 2 weeks. Patients who fulfilled the inclusion criteria were included in the study. All patients and their relatives were informed about the study in their vernacular language and written consent was taken.
Detailed history of each patient was taken. Complete clinical examination was done and all the routine investigations like Complete Blood Count, Renal function tests, HbA1c, Thyroid profile, Liver function tests, Renal function tests, fasting blood sugar , Ultrasound whole abdomen were done.
The data collected was compiled and analysed statistically. Statistical analysis was done using percentages, mean values, standard deviation, Chi-square test. The level of significance used was 0.05 level for the corresponding degree of freedom to draw the inference. A p-value < 0.05 was considered statistically significant and a p > 0.05 was considered as not statistically significant. Figure 2 ). 
Figure 2: Mean serum iron , TIBC and serum ferritin in different BMI groups
In this study, there is statistically significant difference in Mean Serum Ferritin levels between obese women and healthy controls (p value= 0.001 (Table 4 ). (Table 6 ). 
DISCUSSION
In this present study, author have evaluated the levels of Serum Iron, TIBC and Serum Ferritin in obese women of reproductive age and have compared this with controls.
Iron and TIBC
In this study, mean serum iron in obese group patients (55.87±10.23) was significantly lower(p<0.028) than healthy controls (61.66 ±15.22). In this study, mean TIBC in obese group patients (346.98±43.34) was significantly lower (p<0.022) than healthy controls (369.94±54.46). The results of this is similar to study conducted by Neymotin F et al, results suggested a negative relationship between levels of iron blood content and individual BMI. 6 Other studies that supported this study is the study conducted by Del Giudice EM et al, also showed lower iron and transferrin saturation in obese children compared with controls. 7 Cepeda-Lopez et al, found that overweight individuals are at higher risk of iron deficiency than normal weight individuals. 8 Cepeda-Lopez AC et al, showed that obese Mexican women had significantly higher risk of iron deficiency than normal weight individuals. 9 Stankowiak-Kulpa H et al, showed that obese women were characterized by a significantly lowere mean Red blood cell volume, serum iron level, and transferrin saturation. 10 Study conducted by Zhao L et al, concluded that obesity is significantly associated with iron deficiency, and early monitoring and treatment of iron deficiency and obese individuals was recommended. 11 Study conducted by Chambers EC et al, showed an inverse association of measures of body fat distribution and total fat mass with serum iron level in Hispanic women. 12 Obesity being a state of chronic low grade inflammation results in activation of hepcidin Ferroportin axis and decreased iron absorption and transport. 5
Ferritin
In Study conducted by Abidullah Khanet et al, Ferritin has been strong positive correlation with BMI. 18 Study conducted by Shattnawi KK et al, showed that plasma ferritin was higher in obese and overweight adolescents versus normal weight adolescents. 19 Study conducted by Iwasaki T et al, showed that serum ferritin was significantly correlated with visceral fat area, subcutaneous fat area, and the hepatic fat content indicating that serum ferritin may be a useful indicator of systemic fat content and degree of insulin resistance.20
The increase in serum ferritin observed in this study maybe due to effect of adipokines which result in chronic low-grade inflammation further resulting in iron sequestration and role of ferritin as a inflammatory marker. Thus, in obese subjects, Serum ferritin may not be a correct indicator.
CONCLUSION
Author conclude that in obese women of reproductive age group, serum Iron and TIBC are significantly decreased compared with controls, whereas serum ferritin is significantly increased compared with controls. Therefore, improvement in BMI to normal range in this age group may improve iron parameters. Obesity adds to the derangements in iron parameters as women of reproductive age group are already predisposed to iron deficiency.
